Endologix Inc. To Participate In Two Investor Conferences In December

IRVINE, Calif., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Shelley Thunen, Chief Financial Officer, is scheduled to present at two investor conferences in December. The first conference is the Piper Jaffray 25th Annual Healthcare Conference in New York.

Help employers find you! Check out all the jobs and post your resume.